BioCentury | Jun 2, 2014
Emerging Company Profile

Oncofactor: Revoking immunity

...cell proteins like PD-1 are among the most hotly pursued and promising immuno-oncology targets, but Oncofactor Corp....
...better safety than targets on T cells and broader activity than some other tumor targets. Oncofactor...
...MedImmune LLC , Gaithersburg, Md. Oncofactor Corp. , Seattle, Wash. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Sidebars Oncofactor Corp....
BioCentury | Feb 3, 2014
Finance

Bicoastal incubation

...Inc. and anti-flu mAb company Theraclone Sciences Inc. , while two companies - cancer company Oncofactor Corp....
BioCentury | Sep 5, 2011
Strategy

Back to School 2011: Innovation & collaboration

...York, N.Y. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Novo Nordisk A/S (CSE:NVO; NYSE:NVO), Bagsvaerd, Denmark Oncofactor Corp....
...Arch include Acylin Therapeutics Inc. , a developer of cellular acylation inhibitors; cancer immunotherapy company Oncofactor Corp....
BioCentury | May 30, 2011
Financial News

Oncofactor completes venture financing

Oncofactor Corp. , Seattle, Wash. Business: Cancer Date completed: 5/24/11 Type: Venture financing Raised: Not disclosed Investors: Accelerator Corp. ; Alexandria Real Estate Equities; Amgen Ventures; Arch Venture Partners; OVP Venture Partners; Pharmaceutical Product Development Inc....
Items per page:
1 - 4 of 4
BioCentury | Jun 2, 2014
Emerging Company Profile

Oncofactor: Revoking immunity

...cell proteins like PD-1 are among the most hotly pursued and promising immuno-oncology targets, but Oncofactor Corp....
...better safety than targets on T cells and broader activity than some other tumor targets. Oncofactor...
...MedImmune LLC , Gaithersburg, Md. Oncofactor Corp. , Seattle, Wash. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Sidebars Oncofactor Corp....
BioCentury | Feb 3, 2014
Finance

Bicoastal incubation

...Inc. and anti-flu mAb company Theraclone Sciences Inc. , while two companies - cancer company Oncofactor Corp....
BioCentury | Sep 5, 2011
Strategy

Back to School 2011: Innovation & collaboration

...York, N.Y. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Novo Nordisk A/S (CSE:NVO; NYSE:NVO), Bagsvaerd, Denmark Oncofactor Corp....
...Arch include Acylin Therapeutics Inc. , a developer of cellular acylation inhibitors; cancer immunotherapy company Oncofactor Corp....
BioCentury | May 30, 2011
Financial News

Oncofactor completes venture financing

Oncofactor Corp. , Seattle, Wash. Business: Cancer Date completed: 5/24/11 Type: Venture financing Raised: Not disclosed Investors: Accelerator Corp. ; Alexandria Real Estate Equities; Amgen Ventures; Arch Venture Partners; OVP Venture Partners; Pharmaceutical Product Development Inc....
Items per page:
1 - 4 of 4